We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

119 hedge funds and large institutions have $654M invested in Lexicon Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 25

5% more capital invested

Capital invested by funds: $626M → $654M (+$28.2M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 123 → 119 (-4)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

Holders
119
Holders Change
-4
Holders Change %
-3.25%
% of All Funds
3.17%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
13
Increased
40
Reduced
25
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
+$5.04M
2
UBS AM
UBS AM
Illinois
+$3.77M
3
BFA
BlackRock Fund Advisors
California
+$3.01M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.19M
5
Renaissance Technologies
Renaissance Technologies
New York
+$917K

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.84M
2
TCT
TIAA CREF Trust
Missouri
-$983K
3
Morgan Stanley
Morgan Stanley
New York
-$715K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$471K
5
Two Sigma Investments
Two Sigma Investments
New York
-$368K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$172K -$5.89K -863 -3%
State Board of Administration of Florida Retirement System
52
State Board of Administration of Florida Retirement System
Florida
$152K – – –
BA
53
BlackRock Advisors
Delaware
$152K +$26K +3,814 +20%
Millennium Management
54
Millennium Management
New York
$148K -$171K -24,975 -53%
RTS
55
Round Table Services
New Jersey
$143K – – –
AIG
56
American International Group
New York
$138K – – –
VOYA Investment Management
57
VOYA Investment Management
Georgia
$131K – – –
AL
58
Airain Ltd
Guernsey
$114K +$54.8K +8,026 +87%
Bank of America
59
Bank of America
North Carolina
$111K +$724 +106 +0.6%
Citigroup
60
Citigroup
New York
$106K -$39.5K -5,787 -26%
Commonwealth Equity Services
61
Commonwealth Equity Services
Massachusetts
$103K +$29.8K +4,357 +39%
Cambridge Investment Research Advisors
62
Cambridge Investment Research Advisors
Iowa
$100K – – –
GI
63
GAMCO Investors
Connecticut
$99K – – –
KFC
64
Klingenstein Fields & Co
New York
$99K – – –
GF
65
Gabelli Funds
New York
$94K -$245K -35,857 -72%
CSS
66
Cubist Systematic Strategies
Connecticut
$93K -$100K -14,643 -51%
AC
67
Amici Capital
New York
$83K +$85.5K +12,515 New
T. Rowe Price Associates
68
T. Rowe Price Associates
Maryland
$81K -$5.84M -855,399 -99%
UBS Group
69
UBS Group
Switzerland
$77K +$30.4K +4,448 +62%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$75K +$77.1K +11,286 New
M&T Bank
71
M&T Bank
New York
$69K – – –
GAM
72
Gotham Asset Management
New York
$69K +$71.8K +10,509 New
CLOS
73
Compagnie Lombard Odier SCmA
Switzerland
$50K – – –
Northwestern Mutual Wealth Management
74
Northwestern Mutual Wealth Management
Wisconsin
$50K +$47.8K +7,000 +1,275%
Legal & General Group
75
Legal & General Group
United Kingdom
$45K – – –
1 2
3
4 5

LXRX Hedge Fund Activity: Q1 2015 in Review

119 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q1 2015, worth a combined $654M — up 4.5% from $626M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LXRX and 13 opened new positions — a net loss of 3 holders — while 25 trimmed existing stakes and 40 added.

The largest buyer was Sabby Management, adding an estimated $5.04M. The largest seller was T. Rowe Price Associates, cutting an estimated $5.84M.

  • 119 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q1 2015, down from 123 in Q4 2014.
  • Funds reported $654M of Lexicon Pharmaceuticals stock for Q1 2015, up 4.5% quarter-over-quarter.
  • 13 funds opened new Lexicon Pharmaceuticals positions in Q1 2015 and 16 closed out, a net change of -3 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q1 2015 was Sabby Management, an estimated $5.04M added.
  • The largest Lexicon Pharmaceuticals seller in Q1 2015 was T. Rowe Price Associates, an estimated $5.84M sold.

Based on aggregated 13F filings for Q1 2015.